GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AFT Pharmaceuticals Ltd (ASX:AFP) » Definitions » Other Cash Receipts from Operating Activities

AFT Pharmaceuticals (ASX:AFP) Other Cash Receipts from Operating Activities : A$0.0 Mil (TTM As of Sep. 2023)


View and export this data going back to 2015. Start your Free Trial

What is AFT Pharmaceuticals Other Cash Receipts from Operating Activities?

AFT Pharmaceuticals's Other Cash Receipts from Operating Activities for the six months ended in Sep. 2023 was A$0.0 Mil.

AFT Pharmaceuticals's Other Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Sep. 2023 was A$0.0 Mil.


AFT Pharmaceuticals Other Cash Receipts from Operating Activities Historical Data

The historical data trend for AFT Pharmaceuticals's Other Cash Receipts from Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AFT Pharmaceuticals Other Cash Receipts from Operating Activities Chart

AFT Pharmaceuticals Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Other Cash Receipts from Operating Activities
Get a 7-Day Free Trial - - - - -

AFT Pharmaceuticals Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Other Cash Receipts from Operating Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

AFT Pharmaceuticals Other Cash Receipts from Operating Activities Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Other Cash Receipts from Operating Activities represents cash flow received from other operating activities in the direct cash flow method.

GuruFocus lists following items in "Cash Receipts from Operating Activities" section for non-financial companies:
Receipts from Customers
Receipts from Government Grants
Other Cash Receipts from Operating Activities

Other Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AFT Pharmaceuticals Other Cash Receipts from Operating Activities Related Terms

Thank you for viewing the detailed overview of AFT Pharmaceuticals's Other Cash Receipts from Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.


AFT Pharmaceuticals (ASX:AFP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AFT Pharmaceuticals Ltd (ASX:AFP) » Definitions » Other Cash Receipts from Operating Activities
Traded in Other Exchanges
Address
129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Maxigesic, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.

AFT Pharmaceuticals (ASX:AFP) Headlines

No Headlines